arm_3

1 clinical trial

1 product

1 indication

Clinical trial

An Open-Label, Single-Arm Study of Autologous Anti-HER2 Chimeric Antigen Receptor Monocytes (CT-0525), in Participants With HER2 Over Expressing Solid Tumors

Status: Recruiting, Estimated PCD: 2025-03-31

Product

Observational study of circulating tumor cells

Indication